Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Chronic hepatitis B virus (HBV) infection in children: 25 years' experience.

Popalis C, Yeung LT, Ling SC, Ng V, Roberts EA.

J Viral Hepat. 2013 Apr;20(4):e20-6. doi: 10.1111/jvh.12019. Epub 2012 Nov 19.

PMID:
23490385
2.

[Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].

Zhou HJ, Li SG, Wen FY, Yang XY, Wu JL, Tan B, Fu J.

Zhonghua Gan Zang Bing Za Zhi. 2009 Aug;17(8):564-8. Chinese.

PMID:
19719911
3.

Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.

Dikici B, Bosnak M, Ucmak H, Dagli A, Ece A, Haspolat K.

J Gastroenterol Hepatol. 2003 Feb;18(2):218-22.

PMID:
12542609
4.

Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection.

Hom X, Little NR, Gardner SD, Jonas MM.

Pediatr Infect Dis J. 2004 May;23(5):441-5.

PMID:
15131468
5.

Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.

Ni YH, Chang MH, Chen PJ, Tsai KS, Hsu HY, Chen HL, Tsuei DJ, Chen DS.

Gastroenterology. 2007 Jun;132(7):2340-5. Epub 2007 Apr 11.

PMID:
17570209
6.

Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.

Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.

J Infect Dis. 2013 Apr;207(7):1047-57. doi: 10.1093/infdis/jis943. Epub 2013 Jan 8.

PMID:
23300165
7.

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.

Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmundson S, Condreay LD, Chien RN; Asia Hepatitis Lamivudine Study Group.

Hepatology. 2001 Jun;33(6):1527-32.

PMID:
11391543
8.

Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-year prospective study.

Lu H, Geng da Y, Shen F, Zhang JY, Lu B, Ma LX.

Virol J. 2011 Sep 21;8:444. doi: 10.1186/1743-422X-8-444.

9.

Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection.

Tseng YR, Wu JF, Ni YH, Chen HL, Chen CC, Wen WH, Hsu HY, Chang MH.

Liver Int. 2011 Oct;31(9):1373-80. doi: 10.1111/j.1478-3231.2011.02574.x. Epub 2011 Jun 28.

PMID:
21745315
10.

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.

Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.

J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.

PMID:
24004660
11.

[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].

Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.

Mikrobiyol Bul. 2007 Jan;41(1):87-93. Turkish.

PMID:
17427556
13.

Role of serum dehydroepiandrosterone sulfate level on the clearance of chronic hepatitis B virus infection.

Wu JF, Tsai WY, Tung YC, Chen HL, Ni YH, Hsu HY, Chang MH.

J Gastroenterol. 2014 May;49(5):900-6. doi: 10.1007/s00535-013-0831-0. Epub 2013 Jun 1.

PMID:
23728318
15.

The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.

Demirören K, Kocamaz H, Doğan Y.

Turk J Gastroenterol. 2015 Jan;26(1):36-41. doi: 10.5152/tjg.2015.4636.

16.

Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls.

Vo Thi Diem H, Bourgois A, Bontems P, Goyens P, Buts JP, Nackers F, Tonglet R, Sokal EM.

J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):141-5.

PMID:
15699686
17.

Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.

Fischler B, Nyström J, Björnsdottir T, Lindh G, Hultgren C.

J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):75-83.

PMID:
17592368
18.

Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.

Fung J, Lai CL, Young J, Wong DK, Yuen J, Seto WK, Yuen MF.

Am J Gastroenterol. 2011 Oct;106(10):1766-73. doi: 10.1038/ajg.2011.253. Epub 2011 Aug 9.

PMID:
21826112
20.

HBeAg seroconversion in children infected during early childhood with hepatitis B virus.

Roushan MR, Bijani A, Ramzaninejad S, Roushan MH, Amiri MJ, Baiani M.

J Clin Virol. 2012 Sep;55(1):30-3. doi: 10.1016/j.jcv.2012.05.007. Epub 2012 Jun 23.

PMID:
22727680

Supplemental Content

Support Center